GRP and medullary thyroid gland carcinoma: Moreover, one patient treated at our center who had the mutation C634R presented with T2aN0M0 stage MTC and initially markedly elevated bCtn (3600.80 pg/mL) and slightly elevated CEA (18.20 ng/mL), whereas the proGRP levels were consistently within the reference range.